Cancer drug markups hit 700% despite the 2019 cap. Can govt get it right this time?
The NPPA has notified fresh price revisions for 137 non-scheduled anti-cancer drugs. The move exposes returning trade margins while leaving several costly originator brands unchanged.
3 Nov 02:00 · India Today